SCHEMBL14415670

SCHEMBL14415670

NCCC1c2ccccc2Sc2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.55
HRH1 P35367 2/20 0.55
CYP2D6 P10635 2/20 0.51
IDO1 P14902 1/20 0.44
GRM5 P41594 2/20 0.44
GRM1 Q13255 2/20 0.44
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41
TBXA2R P21731 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001557 0.83 HTR2A (0.58) HTR2AHRH1CYP2D6GRM5GRM1
SCHEMBL29265310 0.76 CYP2D6 (0.49) HTR2AHRH1CYP2D6GRM5GRM1
SCHEMBL223348 0.76 HTR2A (0.67) HTR2AHRH1IDO1
SCHEMBL11834975 0.75 CYP2D6 (0.59) HTR2AHRH1CYP2D6GRM5GRM1
SCHEMBL13319990 0.74 CYP2D6 (0.46) HTR2AHRH1CYP2D6GRM5GRM1
SCHEMBL27276181 0.73 CYP2D6 (0.46) CYP2D6GRM5GRM1LMNATP53
SCHEMBL8256345 0.72 HTR2A (0.69) HTR2AHRH1CYP2D6IDO1LMNA
SCHEMBL13962175 0.72 CYP2D6 (0.45) HTR2AHRH1CYP2D6GRM5GRM1
SCHEMBL8255138 0.71 HTR2A (0.78) HTR2AHRH1IDO1CHRM1ADRA1A
SCHEMBL16617866 0.71 CYP2D6 (0.56) HTR2ACYP2D6GRM5GRM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed